GlassScriptPhysician profile
Samantha Pollock
NPI 1366997306
$2,509.38
in general payments reported to CMS, 2019-2025
9 companies · $645 in 2025
The $645 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.89 · 2022: $78.58 · 2023: $54.79 · 2024: $1,634 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423 · Travel and Lodging: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.30 |
| Travel and Lodging | $910.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,880.56 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Astrazeneca Pharmaceuticals LP | $175.47 | 2021-2022 | |
| Solventum Corporation | $146.61 | 2025 | Prevena |
| Edwards Lifesciences Corporation | $120.13 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Organogenesis INC. | $80.38 | 2023-2025 | Cygnus Dual, Affinity, Puraply |
| Convatec INC. | $44.42 | 2025 | |
| Smith+Nephew, INC. | $25.36 | 2024 | Collagenase Santyl, Versajet |
| Zimmer Biomet Holdings, INC. | $22.65 | 2023 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Fidia Pharma USA INC. | $13.80 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Pollock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.